Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director | August 10, 2023 | August 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date August 10, 2023 · Filed August 14, 2023
Jointly reported with SkyKnight Aero Holdings, LLC, SkyKnight Capital, L.P., SkyKnight Capital Management, LLC, SkyKnight Capital Fund II, L.P., SkyKnight Capital II GP, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,815,117 |
Last balance in matching sequence
After 2023-08-11 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-08-10 · Sale · Disposed 90,152 · Balance 2,952,904 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F2: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Row 3 · 2023-08-11 · Sale · Disposed 137,787 · Balance 2,815,117 F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F2: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectBy SkyKnight Capital Fund II, L.P. | 5,565,126 |
Last balance in matching sequence
After 2023-08-11 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2023-08-10 · Sale · Disposed 38,636 · Balance 5,624,178 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Row 4 · 2023-08-11 · Sale · Disposed 59,052 · Balance 5,565,126 F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectBy SkyKnight Aero Holdings II, LLC | 200,200 |
Reported balance
Holding disclosure · report date 2023-08-10 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 200,200 F5: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F2: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F3: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2023 Filed Aug 14, 2023 20:23 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 59,052 | $14.02 | $827,613.78 |
DisclosureSEC source: 0000950170-23-042448 · ownership.xml · nonDerivative · entry 4 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By SkyKnight Capital Fund II, L.P. Disclosed balance after: 5,565,126 F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:23 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 137,787 | $14.02 | $1,931,084.81 |
DisclosureSEC source: 0000950170-23-042448 · ownership.xml · nonDerivative · entry 3 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,815,117 F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:23 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 38,636 | $14.05 | $542,688.98 |
DisclosureSEC source: 0000950170-23-042448 · ownership.xml · nonDerivative · entry 2 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By SkyKnight Capital Fund II, L.P. Disclosed balance after: 5,624,178 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · ownership.nature: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:23 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 90,152 | $14.05 | $1,266,293.02 |
DisclosureSEC source: 0000950170-23-042448 · ownership.xml · nonDerivative · entry 1 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,952,904 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 200 | $17.00 | $3,399.00 |
DisclosureSEC source: 0000899243-22-023344 · doc4.xml · nonDerivative · entry 2 SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,200 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100,000 | $16.78 | $1,678,270.00 |
DisclosureSEC source: 0000899243-22-023344 · doc4.xml · nonDerivative · entry 1 SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.59 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 99,900 | $17.07 | $1,705,592.70 |
DisclosureSEC source: 0000899243-22-022818 · doc4.xml · nonDerivative · entry 2 SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SkyKnight Aero Holdings II, LLC Disclosed balance after: 100,000 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.93 to $17.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.nature: Shares held by SkyKnight Aero Holdings II. SkyKnight Capital is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100 | $16.95 | $1,695.00 |
DisclosureSEC source: 0000899243-22-022818 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SkyKnight Aero Holdings II, LLC Disclosed balance after: 100 F1 · shares: This transaction is being reported by SkyKnight Capital, L.P. ("SkyKnight Capital"), SkyKnight Capital Management, LLC ("SkyKnight Capital Management") and Matthew Ebbel. SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II") has filed a Form 3 reporting the shares purchased in this transaction. F2 · ownership.nature: Shares held by SkyKnight Aero Holdings II. SkyKnight Capital is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100,000 | $17.22 | $1,722,010.00 |
DisclosureSEC source: 0000899243-22-022559 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,043,056 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.0548 to $17.4650. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:35 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 7,923 | $17.39 | $137,785.72 |
DisclosureSEC source: 0000899243-22-022193 · doc4.xml · nonDerivative · entry 2 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,943,056 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.06 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:35 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 5,999 | $17.50 | $104,970.50 |
DisclosureSEC source: 0000899243-22-022193 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935,133 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.47 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:40 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 35,091 | $17.57 | $616,499.74 |
DisclosureSEC source: 0000899243-22-021040 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,929,134 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.45 to $17.65. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 200 | $17.50 | $3,500.00 |
DisclosureSEC source: 0000899243-22-019927 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,894,043 F1 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 24, 2022 Filed May 24, 2022 20:43 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100,000 | $17.27 | $1,727,230.00 |
DisclosureSEC source: 0000899243-22-019372 · doc4.xml · nonDerivative · entry 3 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,893,843 F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.00 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 23, 2022 Filed May 24, 2022 20:43 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 9,300 | $17.44 | $162,157.59 |
DisclosureSEC source: 0000899243-22-019372 · doc4.xml · nonDerivative · entry 2 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,793,843 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.21 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:43 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100,000 | $17.33 | $1,732,940.00 |
DisclosureSEC source: 0000899243-22-019372 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784,543 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 21,632 | $16.20 | $350,498.97 |
DisclosureSEC source: 0000899243-22-018602 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,684,543 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.94 to $16.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 13, 2022 Filed May 16, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100,000 | $15.94 | $1,593,960.00 |
DisclosureSEC source: 0000899243-22-018138 · doc4.xml · nonDerivative · entry 3 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662,911 F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.64 to $16.39. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 55,502 | $15.33 | $851,078.77 |
DisclosureSEC source: 0000899243-22-018138 · doc4.xml · nonDerivative · entry 2 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,562,911 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.16 to $15.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 24,652 | $14.77 | $364,080.46 |
DisclosureSEC source: 0000899243-22-018138 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,507,409 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.16 to $15.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 21:01 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 25,000 | $15.25 | $381,167.50 |
DisclosureSEC source: 0000899243-22-011073 · doc4.xml · nonDerivative · entry 2 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,482,757 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.21 to $15.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F1 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 21:01 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 17,486 | $15.50 | $271,033.00 |
DisclosureSEC source: 0000899243-22-011073 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,457,757 F1 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 23:05 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 13,352 | $15.00 | $200,265.31 |
DisclosureSEC source: 0000899243-22-009977 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,440,271 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.98 to $15.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 19, 2021 Filed Mar 8, 2022 23:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | ConversionSeries C Preferred Stock · Derivative | 11,710.45 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009973 · doc4.xml · derivative · entry 4 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SkyKnight Capital Fund II, L.P. Disclosed balance after: 0 Underlying: Class A Common Stock · 1,171,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F3 · ownership.nature: Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 19, 2021 Filed Mar 8, 2022 23:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | ConversionSeries C Preferred Stock · Derivative | 27,324.4 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009973 · doc4.xml · derivative · entry 3 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,732,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 19, 2021 Filed Mar 8, 2022 23:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | ConversionClass A Common Stock | 1,171,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-009973 · doc4.xml · nonDerivative · entry 2 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SkyKnight Capital Fund II, L.P. Disclosed balance after: 2,426,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F3 · ownership.nature: Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| March 19, 2021 Filed Mar 8, 2022 23:00 UTC | AdaptHealth Corp. AHCO · Entity 5183 | ConversionClass A Common Stock | 2,732,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-009973 · doc4.xml · nonDerivative · entry 1 SkyKnight Aero Holdings, LLC · CIK 0001793034 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director SkyKnight Capital Fund II, L.P. · CIK 0001748212 · Director SkyKnight Capital II GP, LLC · CIK 0001842706 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,662,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F1 · price: On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.